Paper8401490
The interleukin-2 receptor gamma chain maps to Xq13.1 and is mutated in X-linked severe combined immunodeficiency, SCIDX1.
Puck JM and 6 others. Hum Mol Genet, 1993. Cited by 229 papers, by iCite.
Cite this record
ConductScience Library. The interleukin-2 receptor gamma chain maps to Xq13.1 and is mutated in X-linked severe combined immunodeficiency, SCIDX1. Papers, record 8401490. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8401490
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics22
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Genetic Linkage | Major topic |
| Point Mutation | Major topic |
| Receptors, Interleukin-2 | Major topic |
| Severe Combined Immunodeficiency | Major topic |
| X Chromosome | Major topic |
| Amino Acid Sequence | |
| Base Sequence | |
| Chromosome Mapping | |
| Chromosomes, Artificial, Yeast | |
| Cloning, Molecular | |
| DNA Primers | |
| Exons | |
| Female | |
| Gene Library | |
| Humans | |
| In Situ Hybridization | |
| Lymphocytes | |
| Macromolecular Substances | |
| Male | |
| Molecular Sequence Data | |
| Pedigree | |
| Polymerase Chain Reaction |
Source PubMed
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| CA09615 | NCI NIH HHS | United States | T32CA009615 | PubMed and NIH | NIH RePORTER |
| HD23679 | NICHD NIH HHS | United States | R01HD023679 | PubMed and NIH | NIH RePORTER |
| HG00233 | NHGRI NIH HHS | United States | R01HG000233 | PubMed and NIH | NIH RePORTER |
Trials3
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record | Source |
|---|---|---|---|---|
| NCT00006335 | Influences on Female Adolescents' Decisions Regarding Testing for Carrier Status of XSCID | Background | ClinicalTrials.gov | |
| NCT00028236 | Stem Cell Gene Therapy to Treat X-Linked Severe Combined Immunodeficiency (XSCID) | Background | ClinicalTrials.gov | |
| NCT00128973 | Evaluation of Patients With Immune Function Abnormalities | Background | ClinicalTrials.gov |
Cited by76
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 229 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42797625 | Stepwise Evolution of Immunodeficient Mouse Models: Focus on NCG Strains and Their Applications in Humanized Immune System Research. | Vaccines (Basel) | 2026 | https://conductscience.org/library/papers/42797625 | PubMed |
| 39967341 | Targeting γc family cytokines with biologics: current status and future prospects. | MAbs | 2025 | https://conductscience.org/library/papers/39967341 | PubMed |
| 39720273 | Novel IL2RG gene mutation causing primary combined immunodeficiency disease: A case report and literature review. | Cent Eur J Immunol | 2024 | https://conductscience.org/library/papers/39720273 | PubMed |
| 39450341 | Case of T-B+NK+ X-Linked Severe Combined Immunodeficiency Disease. | Case Rep Med | 2024 | https://conductscience.org/library/papers/39450341 | PubMed |
| 38166538 | ZSCAN25 methylation predicts seizures and severe alcohol withdrawal syndrome. | Epigenetics | 2024 | https://conductscience.org/library/papers/38166538 | PubMed |
| 38022498 | Too much of a good thing: a review of primary immune regulatory disorders. | Front Immunol | 2023 | https://conductscience.org/library/papers/38022498 | PubMed |
| 37863939 | Inborn errors of immunity: an expanding universe of disease and genetic architecture. | Nat Rev Genet | 2024 | https://conductscience.org/library/papers/37863939 | PubMed |
| 36553615 | Challenges in Gene Therapy for Somatic Reverted Mosaicism in X-Linked Combined Immunodeficiency by CRISPR/Cas9 and Prime Editing. | Genes (Basel) | 2022 | https://conductscience.org/library/papers/36553615 | PubMed |
| 35764638 | Lentivector cryptic splicing mediates increase in CD34+ clones expressing truncated HMGA2 in human X-linked severe combined immunodeficiency. | Nat Commun | 2022 | https://conductscience.org/library/papers/35764638 | PubMed |
| 35498802 | Novel IL2RG Gene Mutation in One of Dizygotic Twins Causing Profound Changes of Receptor Structure. | Front Pediatr | 2022 | https://conductscience.org/library/papers/35498802 | PubMed |
| 35052377 | Somatic Reversion of a Novel IL2RG Mutation Resulting in Atypical X-Linked Combined Immunodeficiency. | Genes (Basel) | 2021 | https://conductscience.org/library/papers/35052377 | PubMed |
| 34248995 | Case Report: Interleukin-2 Receptor Common Gamma Chain Defect Presented as a Hyper-IgE Syndrome. | Front Immunol | 2021 | https://conductscience.org/library/papers/34248995 | PubMed |
| 33329605 | Immune Reconstitution After Gene Therapy Approaches in Patients With X-Linked Severe Combined Immunodeficiency Disease. | Front Immunol | 2020 | https://conductscience.org/library/papers/33329605 | PubMed |
| 31799703 | The IL-2RG R328X nonsense mutation allows partial STAT-5 phosphorylation and defines a critical region involved in the leaky-SCID phenotype. | Clin Exp Immunol | 2020 | https://conductscience.org/library/papers/31799703 | PubMed |
| 31304419 | Newborn Screening for Severe Combined Immunodeficiency in the US: Current Status and Approach to Management. | Int J Neonatal Screen | 2017 | https://conductscience.org/library/papers/31304419 | PubMed |
| 30995372 | Lentiviral Gene Therapy Combined with Low-Dose Busulfan in Infants with SCID-X1. | N Engl J Med | 2019 | https://conductscience.org/library/papers/30995372 | PubMed |
| 30850927 | A synonymous splice site mutation in IL2RG gene causes late-onset combined immunodeficiency. | Int J Hematol | 2019 | https://conductscience.org/library/papers/30850927 | PubMed |
| 30261899 | T cell dynamics and response of the microbiota after gene therapy to treat X-linked severe combined immunodeficiency. | Genome Med | 2018 | https://conductscience.org/library/papers/30261899 | PubMed |
| 30191136 | Innovation for rare diseases and bioethical concerns: A thin thread between medical progress and suffering. | World J Clin Pediatr | 2018 | https://conductscience.org/library/papers/30191136 | PubMed |
| 29606506 | Nuclease-free Adeno-Associated Virus-Mediated Il2rg Gene Editing in X-SCID Mice. | Mol Ther | 2018 | https://conductscience.org/library/papers/29606506 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| IL2RG | 3561 | Swiss-Prot's references | https://conductscience.org/library/genes/3561 | NCBI Gene |
| IL2 | 3558 | PubTator's text mining | https://conductscience.org/library/genes/3558 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/8401490
GET https://conductscience.org/api/papers/v1/8401490/cited_by?page=2